Inflammation Research Association proceedings of the sixth international conference Douglas W. MorganAnn F. Welton Editorial Pages: C3 - C3
Interleukin-1β induces cytosolic PLA2 in parallel with prostaglandin E2 in rheumatoid synovial fibroblasts Keren I. HulkowerJohn W. CoffeyDouglas W. Morgan Lipid Mediators Pages: C5 - C7
Inflammatory mediator changes in cotton-top tamarins (CTT) after SC-41930 anti-colitic therapy N. ClappM. HenkeD. Fretland Lipid Mediators Pages: C8 - C10
The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930 T. D. PenningS. W. DjuricD. L. Widomski Lipid Mediators Pages: C11 - C13
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages J. E. MeatsL. SteeleJ. G. Bowen Lipid Mediators Pages: C14 - C16
Platelet activating factor modulates peptidoleukotriene effects on the permeability of bovine aortic endothelial cell to albumin M. G. SiroisG. E. PlanteP. Sirois Lipid Mediators Pages: C17 - C20
Effects of chronic NSAIDs on gastric mucosal injury related to mucosal prostanoids, and plasma drug concentrations in human volunteers K. D. RainsfordC. JamesR. H. Hunt Drugs and Lipid Mediators Pages: C21 - C23
Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage K. D. Rainsford Drugs and Lipid Mediators Pages: C24 - C26
Analgesic activities of PEM-420, the active eutomer of pemedolac T. ChauT. WalterB. Weichman Drugs and Lipid Mediators Pages: C27 - C29
Pharmacological characterization of WAY-121,520: A potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2) K. B. GlaserR. P. CarlsonB. M. Weichman Drugs and Lipid Mediators Pages: C30 - C32
Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor A. KreftJ. NelsonK. Glaser Drugs and Lipid Mediators Pages: C33 - C35
Anti-colitic efficacy of SC-41930 in colitic cotton-top tamarins N. ClappM. HenkeD. Fretland Drugs and Lipid Mediators Pages: C36 - C38
Secretory phospholipase A2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A2 William C. HopeTing ChenDouglas W. Morgan Drugs and Lipid Mediators Pages: C39 - C42
Effect of 5-lipoxygenase inhibitors onin situ LTB4 biosynthesis following calcium ionophore stimulation in the rat pleural cavity A. RaychaudhuriH. ChertockG. DiPasquale Drugs and Lipid Mediators Pages: C43 - C45
Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse B. KotyukA. RaychaudhuriG. DiPasquale Drugs and Lipid Mediators Pages: C46 - C48
Anti-inflammatory properties and inhibition of leukotriene C4 biosynthesisin vitro by flavonoid baicalein fromScutellaria baicalensis georgy roots I. G. ButenkoS. V. GladtchenkoS. V. Galushko Drugs and Lipid Mediators Pages: C49 - C51
Inhibition of endotoxin-induced hypothermia and serum TNF-α levels in CD-1 mice by various pharmacological agents S. J. OchalskiD. A. HartmanR. P. Carlson Regulation of Cytokinses Pages: C52 - C54
Effects of pyridinyl imidazole compounds on murine TNF-α production D. L. OliveraJ. T. LaydonJ. C. Lee Regulation of Cytokinses Pages: C55 - C57
Adjuvant arthritic (AA) rats exhibit enhanced endotoxin-induced plasma TNF (EIPT) levels M. DiMartinoM. SlivjakR. Gagnon Regulation of Cytokinses Pages: C58 - C60
Tumour necrosis factor α production by rat blood and itsex vivo pharmacological modulation S. J. FosterL. M. McCormick Regulation of Cytokinses Pages: C61 - C63
Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms S. KassisU. PrabhakarJ. C. Lee Regulation of Cytokinses Pages: C64 - C66
Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level P. YoungP. McDonnellJ. Lee Regulation of Cytokinses Pages: C67 - C69
The effects of anti-inflammatory and antiallergic drugs on the release of IL-1β and TNF-α in the human whole blood assay D. A. HartmanS. J. OchalskiR. P. Carlson Regulation of Cytokinses Pages: C70 - C72
Effect of protein kinase inhibitors on IL-8/NAP-1 release from human umbilical vein endothelial cells John R. WhiteJohn C. Lee Regulation of Cytokinses Pages: C73 - C76
Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors K. Molnar-KimberL. YonnoB. Weichman Regulation of Cytokinses Pages: C77 - C79
The leukocyte recruitment inhibitor, NPC 15669 accelerates healing in acetic acid-induced colitis V. C. LoweL. Noronha-Blob Immunoregulation Pages: C80 - C82
Prevention and suppression of experimental allergic encephalomyelitis by an orally active leukocyte recruitment inhibitor, NPC 16570 V. C. LoweL. Noronha-Blob Immunoregulation Pages: C83 - C85
Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470 A. E. BergerK. A. DortchM. S. Holm Immunoregulation Pages: C86 - C88
Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells G. M. LewisR. G. CacceseC. C. Bansbach Immunoregulation Pages: C89 - C92
The effects of several diphosphonates on murine bone marrow proliferation K. A. RichardN. D. Staite Immunoregulation Pages: C93 - C95
PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR) David J. WilburnMi K. DongRichard B. Gilbertsen Immunoregulation Pages: C96 - C98
PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat bloodin vitro Mi K. DongRichard B. Gilbertsen Immunoregulation Pages: C99 - C101
Coagulation effects of cyclosporine in liver transplantation R. J. FerranteC. R. SpillertE. J. Lazaro Immunoregulation Pages: C102 - C103
Prothrombotic effects of endothelin-2 (ET-2) G. W. RaffC. R. SpillertE. J. Lazaro Immunoregulation Pages: C104 - C105
Procoagulant property of platelet activating factor (PAF) G. W. RaffC. R. SpillertE. J. Lazaro Immunoregulation Pages: C106 - C106
Impaired activity of thiol-dependent ATPases in rheumatoid mononuclear cell membranes K. MaubachA. D. FoeyN. D. Hall Immunoregulation Pages: C107 - C109
Suppressive effects of a novel antioxidant compound on human T cell functionsin vitro J. K. KalsiK. ClayN. D. Hall Immunoregulation Pages: C110 - C112
Immunomodulatory activity of recombinant IL-1 receptor (IL-1-R) on models of experimental rheumatoid arthritis H. U. SchorlemmerE. J. KanzyR. Kurrle Immunoregulation Pages: C113 - C116
Immunoregulation of SLE-like disease by the IL-1 receptor: Disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice H. U. SchorlemmerE. J. KanzyR. Kurrle Immunoregulation Pages: C117 - C120
Immunosuppressive therapy of organ-specific nephritic autoimmune diseases with 15-deoxyspergualin H. U. SchorlemmerH. P. NeubauerG. Dickneite Immunoregulation Pages: C121 - C124
Additive effects of a bradykinin antagonist, NPC 17761, and a leumedin, NPC 15669, on survival in animal models of sepsis L. OtterbeinV. C. LoweL. Noronha-Blob Lung Inflammation Pages: C125 - C127
Sulfuric acid induces airway hyperresponsiveness to substance P in the guinea pig Peter W. StengelAlison M. BendeleSteven A. Silbaugh Lung Inflammation Pages: C128 - C131
Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs S. N. DesaiG. VanT. C. Noonan Lung Inflammation Pages: C132 - C135
Effect of the 21-aminosteroid, U-74389F, on hyperoxic lung injury in rats I. M. RichardsR. L. GriffinE. J. Jacobsen Lung Inflammation Pages: 136 - 138
Rapamycin inhibits airway leukocyte infiltration and hyperreactivity in guinea pigs J. N. FrancischiD. ConroyP. Sirois Lung Inflammation Pages: C139 - C141
l-glutamate activates peripheral nociceptors B. AultL. M. Hildebrand Lung Inflammation Pages: C142 - C144
A proposed autacoid mechanism controlling mastocyte behaviour Luigi AloeAlberta LeonRita Levi-Montalcini Lung Inflammation Pages: C145 - C147
Peptides based on the conserved prodomain sequence of matrix metalloproteinases inhibit human stromelysin and collagenase A. C. HanglowA. LugoN. Fotouhi Osteoarthritis Pages: C148 - C150
A stromelysin assay for the assessment of metalloprotease inhibitors on human aggregated proteoglycan J. R. DoughtyR. L. GoldbergG. Di Pasquale Osteoarthritis Pages: C151 - C153
Sensitivity of monoclonal antibody, 5-D-4, for the detection of aggrecan, aggrecan fragments, and keratan sulfate C. A. SaphosP. DeyV. L. Moore Osteoarthritis Pages: C154 - C156
